Arch Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Net Income	-6.98	-4.28	-6.57	-4.01	-2.72	-4.81	-7.79	-5.99	-2.95	-8.14	Upgrade
Depreciation & Amortization	0	0	0	0.01	0.01	0.01	0	0	0	0	Upgrade
Share-Based Compensation	0.25	0.5	0.5	0.9	1.18	1.74	2.11	1.1	1.05	1.1	Upgrade
Other Operating Activities	3.36	-0.68	0.11	-1.94	-3.74	-2.85	0.07	0.15	-2.34	3.69	Upgrade
Operating Cash Flow	-3.37	-4.46	-5.96	-5.04	-5.27	-5.91	-5.62	-4.75	-4.24	-3.35	Upgrade
Capital Expenditures	-0	0	-0	-0	0	-0.02	-0.01	0	0	0	Upgrade
Investing Cash Flow	-0	0	-0	-0	0	-0.02	-0.01	0	0	0	Upgrade
Common Stock Issued	2.21	0.01	6.22	2.17	2.75	4.46	5.99	3.11	3.02	2.62	Upgrade
Other Financing Activities	0.64	2.93	1.05	1.66	0.03	0.14	0.6	2.71	4.35	1	Upgrade
Financing Cash Flow	2.85	2.94	7.27	3.83	2.78	4.6	6.58	5.82	7.37	3.62	Upgrade
Net Cash Flow	-0.52	-1.52	1.31	-1.22	-2.49	-1.33	0.96	1.08	3.13	0.28	Upgrade
Free Cash Flow	-3.38	-4.46	-5.96	-5.05	-5.27	-5.93	-5.62	-4.75	-4.24	-3.35	Upgrade
Free Cash Flow Margin	-4461.91%	-28469.68%	-51551.26%	-	-	-	-	-	-	-	Upgrade
Free Cash Flow Per Share	-1.10	-3.71	-5.42	-5.37	-6.33	-7.76	-7.88	-7.82	-10.42	-9.92	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.